GE HealthCare Technologies Inc. Common Stock
GEHCGE HealthCare Technologies Inc. (GEHC) is a global leader in medical imaging, diagnostics, patient monitoring, and healthcare IT solutions. It was spun off from General Electric in 2022 to focus exclusively on healthcare technology, offering advanced equipment and services to improve patient care and clinical outcomes worldwide.
Dividend History
Investors can expect a dividend payout of $0.04 per share, scheduled to be distributed in 21 days on February 13, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| February 13, 2026 | $0.04 | 2026-01-09 | 2026-01-09 |
| November 14, 2025 | $0.04 | 2025-10-24 | 2025-10-24 |
| August 15, 2025 | $0.04 | 2025-07-25 | 2025-07-25 |
| May 15, 2025 | $0.04 | 2025-04-25 | 2025-04-25 |
| February 14, 2025 | $0.04 | 2025-01-14 | 2025-01-14 |
Dividends Summary
- Consistent Payer: GE HealthCare Technologies Inc. Common Stock has rewarded shareholders with 12 dividend payments over the past 3 years.
- Total Returned Value: Investors who held GEHC shares during this period received a total of $0.39 per share in dividend income.
- Latest Payout: The most recent dividend of $0.04/share was paid 70 days ago, on November 14, 2025.
- Yield & Schedule: GEHC currently pays dividends quarterly with an annual yield of 0.17%.
- Dividend Growth: Since 2023, the dividend payout has grown by 16.7%, from $0.03 to $0.04.
- Dividend Reliability: GEHC has maintained or increased its dividend for 12 consecutive payments.
Company News
The global breast cancer imaging market is expected to grow at a CAGR of 7.7% from 2025 to 2033, driven by rising breast cancer incidence, technological advancements in imaging modalities like tomosynthesis and CESM, and increased government healthcare initiatives for early detection and screening.
The global radiochromic film market is projected to grow from USD 144.83 million in 2025 to USD 217.82 million by 2032, at a CAGR of 6.00%. Growth is driven by increasing demand in precision dosimetry, particle therapy, industrial inspections, and precision medicine. Key advancements include self-developing chemistry, high spatial resolution, and...
AI-driven clinical intelligence is transforming medical imaging, with point-of-care diagnostics projected to reach $70.92 billion by 2032. The CMS ACCESS Model launching in July 2026 will reward outcome-based care, driving adoption of software-defined imaging platforms. Key players including VentriPoint Diagnostics, Butterfly Network, Hyperfine, ...
GE Vernova, spun off from General Electric in 2024, has rallied 70% over the past 12 months and is well-positioned to benefit from the global energy boom. The company's Power and Electrification segments are experiencing strong growth driven by AI, data centers, and grid modernization demands. While the Wind segment struggles, management projects...
The global Medical Device Connectivity Market is projected to grow at a CAGR of 23.40% from 2026 to 2032, expanding from USD 2.49 Billion in 2024 to USD 13.4 Billion by 2032. Growth is driven by increasing demand for IoT-enabled healthcare systems, remote patient monitoring, and favorable regulatory frameworks, though high implementation costs an...
